Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Biology
|
| gptkbp:administered_by |
intravenous infusion
|
| gptkbp:approves |
gptkb:2006
gptkb:FDA |
| gptkbp:class |
recombinant human iduronate-2-sulfatase
|
| gptkbp:developed_by |
gptkb:Shire_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
idursulfase
|
| gptkbp:indication |
gptkb:Mucopolysaccharidosis_II
|
| gptkbp:marketed_as |
gptkb:Elaprase
|
| gptkbp:route_of_administration |
IV
|
| gptkbp:used_for |
treatment of Hunter syndrome
|
| gptkbp:bfsParent |
gptkb:Elaprase
|
| gptkbp:bfsLayer |
6
|